Nasdaq · Biotech stocks database

TECH — Bio-Techne Corp

TECH (Bio-Techne Corp) stock: $72.37, $11.35B market cap, $264.7M cash, $11.08B EV, $11.86B fully diluted market cap. Data from Fully Diluted's biotech stocks database.

Share price

$72.37

Market cap

$11,348.9M

Cash

$264.7M

Enterprise value

$11,084.2M

Balance sheet

Cash	$264.7M
Debt	$0.0M
Net cash	$264.7M
Enterprise value	$11,084.2M
Basic shares	156.1M shares
Fully diluted shares	163.9M shares
Fully diluted market cap	$11,863.4M
Cash per share	$1.70

Cash figures as of 2026-06-30. Database snapshot: 2026-09-21.

Price history

Loading TECH daily closes…

Loading price history…

Active clinical trials

Trial	Phase	Status	Role	Sponsor	BP	Condition(s)	Mgmt guide
NCT06966089	Not disclosed	Not yet recruiting	Collaborator	Icahn School of Medicine at Mount Sinai	—	Prostate Cancer	—

Sponsor-matched active trials from ClinicalTrials.gov (0 as sponsor, 1 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.

View all 1 active trials for Icahn School of Medicine at Mount Sinai on ClinicalTrials.gov

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 714 stocks.

Subscribe to Compounding Ego